Javascript must be enabled to continue!
MON-193 Glucocorticoid Excess and Its Association with Metabolic and Cardiovascular Complications in Primary Aldosteronism
View through CrossRef
Abstract
Objective: To investigate autonomous cortisol secretion in patients with primary aldosteronism and its effect on metabolism and cardiovascular events (CVE) in patients with primary aldosteronism (PA).
Methods: This study included 163 patients with PA and 105 sex- and age-matched patients with essential hypertension (EH). Clinical and laboratory data were collected. The expression of cortisol synthase (CYP11B1) and aldosterone synthase (CYP11B2) was investigated in adenoma tissues from 44 patients with aldosterone-producing adenoma (APA) by employing immunohistochemistry.
Results: 1) CYP11B2 was expressed in 36 patients with APA and was absent in 8 patients, while CYP11B1 immunoreactivity was detected in all tested patients with APA; 2) Compared with patients with EH, midnight cortisol concentration (104.81±90.86 vs 76.87±65.86), 24-h urine free cortisol level (726.04±309.87 vs 630.65±168.2), and cortisol level after 1mg-DST [35.6(27.6,75.73)vs 27.6(27.60,29.27)]were all significantly increased in patients with PA(all P<0.01); 3) Midnight cortisol concentration is positively associated with systolic blood pressure (SBP) (r=0.147 P<0.05), LDL-C (r=0.194 P<0.05), HOMA-IR (r=0.262 P<0.05), HOMA-β (r=0.313 P<0.05) and fasting insulin level (r=0.329 P<0.05) in patients with PA. In multiple linear regression analysis, midnight cortisol concentration was a postitive predictor for SBP (β=0.185 P<0.05), HOMA-IR (β=0.331 P<0.05) and HOMA-β (β=0.390 P<0.05); 4) Of the 163 patients with PA, 35 had a history of CVE, including 22 with stroke, eight with myocardial infarction, three with atrial fibrillation, and two with heart failure. The multivariate logistic-regression analyses revealed older age (OR 1.160 95%CI 1.041-1.294 P <0.001) and higher serum aldosterone level (OR 1.013 95%CI 1.000-1.026 P <0.05) were independent risk factors of CVE, serum cortisol level was not associated with the increased risk of CVE in patients with PA (OR 0.997 95%CI 0.985-1.009 P =0.570).
Conclusion: Excess cortisol secretion was common in PA. Cortisol excretion is correlated with metabolic disorders, but not associated with increased risk of CVE in patients with PA.
The Endocrine Society
Title: MON-193 Glucocorticoid Excess and Its Association with Metabolic and Cardiovascular Complications in Primary Aldosteronism
Description:
Abstract
Objective: To investigate autonomous cortisol secretion in patients with primary aldosteronism and its effect on metabolism and cardiovascular events (CVE) in patients with primary aldosteronism (PA).
Methods: This study included 163 patients with PA and 105 sex- and age-matched patients with essential hypertension (EH).
Clinical and laboratory data were collected.
The expression of cortisol synthase (CYP11B1) and aldosterone synthase (CYP11B2) was investigated in adenoma tissues from 44 patients with aldosterone-producing adenoma (APA) by employing immunohistochemistry.
Results: 1) CYP11B2 was expressed in 36 patients with APA and was absent in 8 patients, while CYP11B1 immunoreactivity was detected in all tested patients with APA; 2) Compared with patients with EH, midnight cortisol concentration (104.
81±90.
86 vs 76.
87±65.
86), 24-h urine free cortisol level (726.
04±309.
87 vs 630.
65±168.
2), and cortisol level after 1mg-DST [35.
6(27.
6,75.
73)vs 27.
6(27.
60,29.
27)]were all significantly increased in patients with PA(all P<0.
01); 3) Midnight cortisol concentration is positively associated with systolic blood pressure (SBP) (r=0.
147 P<0.
05), LDL-C (r=0.
194 P<0.
05), HOMA-IR (r=0.
262 P<0.
05), HOMA-β (r=0.
313 P<0.
05) and fasting insulin level (r=0.
329 P<0.
05) in patients with PA.
In multiple linear regression analysis, midnight cortisol concentration was a postitive predictor for SBP (β=0.
185 P<0.
05), HOMA-IR (β=0.
331 P<0.
05) and HOMA-β (β=0.
390 P<0.
05); 4) Of the 163 patients with PA, 35 had a history of CVE, including 22 with stroke, eight with myocardial infarction, three with atrial fibrillation, and two with heart failure.
The multivariate logistic-regression analyses revealed older age (OR 1.
160 95%CI 1.
041-1.
294 P <0.
001) and higher serum aldosterone level (OR 1.
013 95%CI 1.
000-1.
026 P <0.
05) were independent risk factors of CVE, serum cortisol level was not associated with the increased risk of CVE in patients with PA (OR 0.
997 95%CI 0.
985-1.
009 P =0.
570).
Conclusion: Excess cortisol secretion was common in PA.
Cortisol excretion is correlated with metabolic disorders, but not associated with increased risk of CVE in patients with PA.
Related Results
Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit
Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit
Introduction:
Primary aldosteronism is the most frequent cause of hypertension although is undetected. The 2016 Endocrine Society guidelines (2016-ESG) recommendations ...
Adrenocortical hypofunction with simultaneous primary aldosteronism
Adrenocortical hypofunction with simultaneous primary aldosteronism
Abstract
Rationale:
Cases of adrenocortical hyperfunction combined with primary aldosteronism have been reported in the literature, and the under...
Supplementary Data from Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition
Supplementary Data from Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition
<p>Supplementary Figure S1. GSEA analyses of subtype-specific genes (PCS1, PCS2 and PCS3) in 42DENZR and 42FENZR cells. Supplementary Figure S2. A) Expression of FOXM1 in dif...
Supplementary Data from Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition
Supplementary Data from Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition
<p>Supplementary Figure S1. GSEA analyses of subtype-specific genes (PCS1, PCS2 and PCS3) in 42DENZR and 42FENZR cells. Supplementary Figure S2. A) Expression of FOXM1 in dif...
Association between N363S and BcLI Polymorphisms of the Glucocorticoid Receptor Gene (NR3C1) and Glucocorticoid Treatment-Related Side Effects in Acute Lymphoblastic Leukemia Patients: A Study from Khyber Pakhtunkhwa, Pakistan
Association between N363S and BcLI Polymorphisms of the Glucocorticoid Receptor Gene (NR3C1) and Glucocorticoid Treatment-Related Side Effects in Acute Lymphoblastic Leukemia Patients: A Study from Khyber Pakhtunkhwa, Pakistan
Objectives: To evaluate the association between N363S and BcLI polymorphisms of the NR3C1 gene and glucocorticoid treatment-related side effects in acute lymphoblastic leukemia pat...
INVESTIGATING CARDIOVASCULAR AND METABOLIC HEALTH PROFILES IN WOMEN WITH AND WITHOUT POLYCYSTIC OVARY SYNDROME: INSIGHTS FROM DISTRICT GHOTKI
INVESTIGATING CARDIOVASCULAR AND METABOLIC HEALTH PROFILES IN WOMEN WITH AND WITHOUT POLYCYSTIC OVARY SYNDROME: INSIGHTS FROM DISTRICT GHOTKI
Background: Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder that impacts women’s reproductive and metabolic health. PCOS is frequently associated with increased ...
Real-Time Classification of Causes of Death Using AI: Sensitivity Analysis (Preprint)
Real-Time Classification of Causes of Death Using AI: Sensitivity Analysis (Preprint)
BACKGROUND
In 2021, the European Union reported >270,000 excess deaths, including >16,000 in Portugal. The Portuguese Directorate-General of H...
Real-Time Classification of Causes of Death Using AI: Sensitivity Analysis
Real-Time Classification of Causes of Death Using AI: Sensitivity Analysis
Background
In 2021, the European Union reported >270,000 excess deaths, including >16,000 in Portugal. The Portuguese Directorate-General of Health develo...

